Fièvre jaune: nouvelles recommandations [Yellow fever: new recommendations].

Détails

ID Serval
serval:BIB_4153D407F0EA
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Fièvre jaune: nouvelles recommandations [Yellow fever: new recommendations].
Périodique
Revue Médicale Suisse
Auteur(s)
Rochat L., Genton B.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2014
Volume
10
Numéro
429
Pages
1014-1019
Langue
français
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Indication for yellow fever vaccination is not always easy to assess. The decision to immunize is not only based on the actual risk of the disease in a specific location, but also on public health considerations in the visited country (in order to respectively avoid epidemics in endemic countries or the introduction of the virus in zones where the vectors mosquitoes are present) and on travelers' risk factors for severe or even fatal vaccine adverse events. WHO has recently published new recommendations regarding vaccination against yellow fever after concluding that one dose of vaccine generates a life-long protection. This article tends to clarify the strategy to adopt in 2013 using cases frequently encountered in the practice of travel medicine.
Mots-clé
Adult, hic" UI="D000349">Africa, Female, Humans, Male, Mass Vaccination/standards, Middle Aged, Practice Guidelines as Topic, Travel, World Health Organization, Yellow Fever/prevention & control, Yellow Fever Vaccine/therapeutic use
Pubmed
Création de la notice
16/02/2015 14:22
Dernière modification de la notice
03/03/2018 16:32
Données d'usage